0456-1201Level 3
Linzess (linaclotide)
**Product type:** Human Prescription Drug
**Active ingredient:** LINACLOTIDE
**Strength:** 145 ug/1
**Dosage form:** Capsule, Gelatin Coated
**Route:** Oral
**Labeler:** Allergan, Inc.
**Marketing category:** NDA (NDA202811)
**Pharmacologic class:** Guanylate Cyclase Activators [MoA], Guanylate Cyclase-C Agonist [EPC]
GET
/api/v1/systems/ndc_fda/nodes/0456-1201Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.